DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02943850 (ClinicalTrials.gov)	April 1, 2017	20/10/2016	CNS10-NPC-GDNF for the Treatment of ALS	Human Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) for the Treatment of Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Biological: Stem cell (HPC) implantation;Device: Stereotactic surgical device	Cedars-Sinai Medical Center	California Institute for Regenerative Medicine (CIRM)	Completed	18 Years	N/A	All	18	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02943850
(ClinicalTrials.gov)

April 1, 2017

20/10/2016

CNS10-NPC-GDNF for the Treatment of ALS

Human Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) for the Treatment of Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Biological: Stem cell (HPC) implantation;Device: Stereotactic surgical device

Cedars-Sinai Medical Center

California Institute for Regenerative Medicine (CIRM)

Completed

18 Years

N/A

All

Phase 1

United States